Concepts (329)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Endometrium | 22 | 2023 | 424 | 7.010 |
Why?
|
Reproductive Medicine | 12 | 2021 | 108 | 6.080 |
Why?
|
Embryo Implantation | 19 | 2023 | 272 | 4.670 |
Why?
|
Preimplantation Diagnosis | 11 | 2021 | 151 | 4.470 |
Why?
|
Infertility | 11 | 2021 | 655 | 3.320 |
Why?
|
Preconception Care | 5 | 2019 | 134 | 2.970 |
Why?
|
Fertilization in Vitro | 12 | 2022 | 1284 | 2.550 |
Why?
|
Andrology | 3 | 2021 | 10 | 2.410 |
Why?
|
Blastocyst | 10 | 2023 | 424 | 2.300 |
Why?
|
Embryo Transfer | 8 | 2022 | 511 | 2.090 |
Why?
|
Reproduction | 5 | 2023 | 668 | 1.990 |
Why?
|
Reproductive Techniques, Assisted | 7 | 2022 | 482 | 1.980 |
Why?
|
Infertility, Female | 7 | 2020 | 784 | 1.900 |
Why?
|
Uterus | 6 | 2019 | 710 | 1.880 |
Why?
|
Aneuploidy | 7 | 2021 | 530 | 1.860 |
Why?
|
Gynatresia | 2 | 2023 | 15 | 1.650 |
Why?
|
Genetic Testing | 9 | 2021 | 3439 | 1.560 |
Why?
|
Endometritis | 3 | 2022 | 48 | 1.540 |
Why?
|
Decidua | 2 | 2021 | 86 | 1.490 |
Why?
|
Pregnancy | 42 | 2024 | 29087 | 1.220 |
Why?
|
Annexin A2 | 2 | 2019 | 44 | 1.130 |
Why?
|
Uterine Diseases | 2 | 2023 | 135 | 0.990 |
Why?
|
Genetic Diseases, Inborn | 2 | 2019 | 587 | 0.940 |
Why?
|
Hysteroscopy | 3 | 2020 | 102 | 0.920 |
Why?
|
Fertility | 5 | 2019 | 770 | 0.850 |
Why?
|
Anniversaries and Special Events | 2 | 2019 | 89 | 0.840 |
Why?
|
Vagina | 2 | 2018 | 825 | 0.840 |
Why?
|
Myometrium | 2 | 2024 | 181 | 0.830 |
Why?
|
Pre-Eclampsia | 2 | 2021 | 1196 | 0.780 |
Why?
|
RNA, Ribosomal, 16S | 3 | 2022 | 947 | 0.720 |
Why?
|
Ectogenesis | 1 | 2019 | 8 | 0.710 |
Why?
|
Dissent and Disputes | 1 | 2020 | 138 | 0.670 |
Why?
|
Bioengineering | 1 | 2019 | 99 | 0.650 |
Why?
|
Forecasting | 4 | 2021 | 2948 | 0.620 |
Why?
|
Genital Diseases, Female | 2 | 2019 | 197 | 0.620 |
Why?
|
Estrogen Receptor alpha | 1 | 2021 | 577 | 0.600 |
Why?
|
Live Birth | 2 | 2022 | 512 | 0.590 |
Why?
|
Sperm Motility | 1 | 2018 | 253 | 0.580 |
Why?
|
Receptors, Progesterone | 1 | 2021 | 1097 | 0.580 |
Why?
|
Embryonic Development | 4 | 2023 | 704 | 0.570 |
Why?
|
Menstrual Cycle | 2 | 2017 | 551 | 0.570 |
Why?
|
Genetic Counseling | 2 | 2017 | 600 | 0.550 |
Why?
|
Cell Communication | 3 | 2023 | 1619 | 0.550 |
Why?
|
Selection, Genetic | 1 | 2021 | 914 | 0.540 |
Why?
|
Oocytes | 2 | 2018 | 1186 | 0.540 |
Why?
|
Reproductive History | 1 | 2017 | 209 | 0.540 |
Why?
|
Pluripotent Stem Cells | 3 | 2013 | 795 | 0.540 |
Why?
|
Complementary Therapies | 1 | 2020 | 484 | 0.540 |
Why?
|
Sequence Analysis, RNA | 2 | 2020 | 2011 | 0.510 |
Why?
|
Biological Evolution | 1 | 2021 | 1074 | 0.510 |
Why?
|
Erectile Dysfunction | 1 | 2018 | 459 | 0.480 |
Why?
|
Chromosome Disorders | 1 | 2017 | 515 | 0.480 |
Why?
|
Female | 57 | 2024 | 379592 | 0.480 |
Why?
|
Mosaicism | 1 | 2017 | 440 | 0.480 |
Why?
|
Totipotent Stem Cells | 1 | 2013 | 16 | 0.450 |
Why?
|
DNA, Bacterial | 1 | 2018 | 1465 | 0.440 |
Why?
|
Diffusion of Innovation | 3 | 2021 | 725 | 0.410 |
Why?
|
Obstetrics | 1 | 2019 | 657 | 0.410 |
Why?
|
History, 21st Century | 4 | 2021 | 1533 | 0.410 |
Why?
|
Continuity of Patient Care | 1 | 2019 | 1048 | 0.400 |
Why?
|
Embryonic Stem Cells | 4 | 2014 | 1294 | 0.400 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2015 | 370 | 0.400 |
Why?
|
Humans | 73 | 2024 | 742088 | 0.400 |
Why?
|
Automation, Laboratory | 2 | 2021 | 101 | 0.380 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2012 | 241 | 0.380 |
Why?
|
Evidence-Based Medicine | 2 | 2020 | 3611 | 0.380 |
Why?
|
Societies, Medical | 2 | 2019 | 3740 | 0.380 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2183 | 0.370 |
Why?
|
Stem Cell Transplantation | 1 | 2018 | 1618 | 0.350 |
Why?
|
Endometriosis | 2 | 2015 | 834 | 0.350 |
Why?
|
Actins | 2 | 2019 | 2120 | 0.350 |
Why?
|
Bacterial Infections | 1 | 2018 | 1389 | 0.350 |
Why?
|
Artificial Intelligence | 2 | 2022 | 2187 | 0.330 |
Why?
|
Heterozygote | 1 | 2015 | 2790 | 0.330 |
Why?
|
Stem Cells | 2 | 2019 | 3563 | 0.330 |
Why?
|
Bone Marrow | 1 | 2019 | 2941 | 0.320 |
Why?
|
Gene Expression Profiling | 7 | 2021 | 9410 | 0.320 |
Why?
|
Pregnancy Complications | 3 | 2019 | 2861 | 0.320 |
Why?
|
Gardnerella vaginalis | 2 | 2018 | 13 | 0.310 |
Why?
|
Spain | 4 | 2021 | 465 | 0.290 |
Why?
|
Research Design | 1 | 2022 | 5979 | 0.290 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2018 | 3585 | 0.290 |
Why?
|
DNA Mutational Analysis | 1 | 2015 | 4187 | 0.280 |
Why?
|
Lactobacillus | 2 | 2018 | 189 | 0.280 |
Why?
|
Ovulation Induction | 3 | 2022 | 274 | 0.280 |
Why?
|
Spermatozoa | 4 | 2021 | 625 | 0.280 |
Why?
|
Policy Making | 2 | 2021 | 554 | 0.270 |
Why?
|
Attitude of Health Personnel | 1 | 2020 | 3839 | 0.270 |
Why?
|
Biopsy | 5 | 2021 | 6756 | 0.260 |
Why?
|
Leiomyoma | 2 | 2022 | 728 | 0.250 |
Why?
|
Cell Differentiation | 6 | 2015 | 11470 | 0.250 |
Why?
|
Germ Cells | 3 | 2014 | 628 | 0.240 |
Why?
|
Cell Culture Techniques | 2 | 2016 | 1670 | 0.230 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 9941 | 0.230 |
Why?
|
Physicians | 1 | 2020 | 4554 | 0.200 |
Why?
|
Culture Media | 2 | 2021 | 902 | 0.190 |
Why?
|
Models, Biological | 2 | 2015 | 9581 | 0.190 |
Why?
|
Fertilization | 1 | 2022 | 195 | 0.190 |
Why?
|
Genetic Code | 1 | 2021 | 154 | 0.190 |
Why?
|
Labor, Obstetric | 1 | 2024 | 333 | 0.180 |
Why?
|
Genome, Human | 1 | 2013 | 4420 | 0.180 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 1 | 2019 | 123 | 0.170 |
Why?
|
Placentation | 1 | 2019 | 82 | 0.170 |
Why?
|
Fibroblasts | 1 | 2010 | 4143 | 0.170 |
Why?
|
Paternal Age | 1 | 2019 | 84 | 0.170 |
Why?
|
Exosomes | 1 | 2023 | 412 | 0.170 |
Why?
|
Quarantine | 1 | 2021 | 167 | 0.170 |
Why?
|
Perinatal Mortality | 1 | 2019 | 105 | 0.160 |
Why?
|
Mycoplasma hominis | 1 | 2018 | 9 | 0.160 |
Why?
|
Signal Transduction | 1 | 2021 | 23387 | 0.160 |
Why?
|
Trophoblasts | 1 | 2019 | 215 | 0.160 |
Why?
|
Fathers | 1 | 2021 | 357 | 0.160 |
Why?
|
Trisomy | 1 | 2019 | 266 | 0.160 |
Why?
|
Embryo, Mammalian | 2 | 2023 | 1692 | 0.160 |
Why?
|
Asymptomatic Diseases | 1 | 2021 | 552 | 0.160 |
Why?
|
Mycoplasma Infections | 1 | 2018 | 118 | 0.160 |
Why?
|
Cicatrix | 1 | 2023 | 761 | 0.150 |
Why?
|
Staphylococcus | 1 | 2018 | 155 | 0.150 |
Why?
|
Prolactin | 1 | 2019 | 669 | 0.150 |
Why?
|
Genetic Predisposition to Disease | 5 | 2021 | 17400 | 0.150 |
Why?
|
Streptococcus | 1 | 2018 | 197 | 0.150 |
Why?
|
Predictive Value of Tests | 3 | 2019 | 15056 | 0.150 |
Why?
|
Leiomyosarcoma | 1 | 2022 | 477 | 0.150 |
Why?
|
Ovary | 1 | 2022 | 981 | 0.150 |
Why?
|
Culture Techniques | 1 | 2018 | 554 | 0.150 |
Why?
|
Pregnancy Rate | 2 | 2019 | 643 | 0.150 |
Why?
|
Asymptomatic Infections | 1 | 2018 | 128 | 0.150 |
Why?
|
RNA, Small Interfering | 2 | 2019 | 3504 | 0.150 |
Why?
|
Klebsiella Infections | 1 | 2018 | 137 | 0.140 |
Why?
|
Enterococcus | 1 | 2018 | 158 | 0.140 |
Why?
|
Prevotella | 1 | 2016 | 79 | 0.140 |
Why?
|
Treatment Refusal | 1 | 2020 | 416 | 0.140 |
Why?
|
Spermatogonia | 1 | 2016 | 29 | 0.140 |
Why?
|
Cell Line | 2 | 2010 | 15994 | 0.140 |
Why?
|
Chlamydia trachomatis | 1 | 2018 | 245 | 0.140 |
Why?
|
Klebsiella pneumoniae | 1 | 2018 | 246 | 0.140 |
Why?
|
Estrogens | 1 | 2003 | 1562 | 0.140 |
Why?
|
Male | 18 | 2021 | 349538 | 0.140 |
Why?
|
Central Nervous System Cysts | 1 | 2016 | 58 | 0.140 |
Why?
|
Bacterial Typing Techniques | 1 | 2016 | 256 | 0.140 |
Why?
|
Telomere-Binding Proteins | 1 | 2016 | 116 | 0.130 |
Why?
|
Chronic Disease | 3 | 2022 | 9144 | 0.130 |
Why?
|
Withholding Treatment | 1 | 2020 | 598 | 0.130 |
Why?
|
Muscle Spasticity | 1 | 2016 | 154 | 0.130 |
Why?
|
Neisseria gonorrhoeae | 1 | 2018 | 238 | 0.130 |
Why?
|
Meta-Analysis as Topic | 1 | 2020 | 1342 | 0.130 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2018 | 341 | 0.130 |
Why?
|
Pathology, Molecular | 1 | 2018 | 325 | 0.120 |
Why?
|
Plasma Cells | 1 | 2018 | 592 | 0.120 |
Why?
|
Chlamydia Infections | 1 | 2018 | 364 | 0.120 |
Why?
|
Government Regulation | 1 | 2019 | 522 | 0.120 |
Why?
|
Cells, Cultured | 5 | 2019 | 19223 | 0.120 |
Why?
|
Registries | 1 | 2010 | 8077 | 0.120 |
Why?
|
Ataxia | 1 | 2016 | 304 | 0.120 |
Why?
|
Stromal Cells | 1 | 2019 | 1353 | 0.120 |
Why?
|
Infant Mortality | 1 | 2019 | 754 | 0.120 |
Why?
|
Escherichia coli Infections | 1 | 2018 | 532 | 0.120 |
Why?
|
Luteinizing Hormone | 1 | 2016 | 864 | 0.120 |
Why?
|
Blastocyst Inner Cell Mass | 1 | 2013 | 6 | 0.120 |
Why?
|
Gonorrhea | 1 | 2018 | 335 | 0.120 |
Why?
|
Placenta | 1 | 2023 | 1694 | 0.120 |
Why?
|
Infant, Newborn, Diseases | 1 | 2019 | 580 | 0.110 |
Why?
|
Streptococcal Infections | 1 | 2018 | 637 | 0.110 |
Why?
|
Blastomeres | 1 | 2013 | 28 | 0.110 |
Why?
|
Leukoencephalopathies | 1 | 2016 | 238 | 0.110 |
Why?
|
Principal Component Analysis | 1 | 2016 | 939 | 0.110 |
Why?
|
Proprotein Convertase 5 | 1 | 2012 | 3 | 0.110 |
Why?
|
Gene Expression Regulation, Developmental | 3 | 2015 | 3617 | 0.110 |
Why?
|
Pilot Projects | 2 | 2016 | 8297 | 0.110 |
Why?
|
Species Specificity | 1 | 2017 | 2479 | 0.110 |
Why?
|
Uterine Neoplasms | 1 | 2022 | 1513 | 0.110 |
Why?
|
Infant, Newborn | 3 | 2023 | 25575 | 0.110 |
Why?
|
Microarray Analysis | 1 | 2015 | 766 | 0.110 |
Why?
|
DEAD-box RNA Helicases | 2 | 2012 | 375 | 0.100 |
Why?
|
Integrin alpha Chains | 1 | 2012 | 97 | 0.100 |
Why?
|
Consensus | 1 | 2021 | 2935 | 0.100 |
Why?
|
Abortion, Spontaneous | 3 | 2019 | 542 | 0.100 |
Why?
|
Animals | 12 | 2023 | 168561 | 0.100 |
Why?
|
Models, Animal | 1 | 2018 | 2170 | 0.100 |
Why?
|
Tissue Donors | 1 | 2021 | 2205 | 0.100 |
Why?
|
Life Change Events | 1 | 2017 | 937 | 0.100 |
Why?
|
DNA, Complementary | 1 | 2015 | 2049 | 0.100 |
Why?
|
Prenatal Care | 1 | 2019 | 1088 | 0.100 |
Why?
|
Genome, Bacterial | 1 | 2016 | 754 | 0.100 |
Why?
|
Autistic Disorder | 1 | 2021 | 1174 | 0.100 |
Why?
|
Bibliometrics | 1 | 2015 | 339 | 0.100 |
Why?
|
Treatment Failure | 1 | 2017 | 2615 | 0.100 |
Why?
|
Thalidomide | 1 | 2016 | 888 | 0.100 |
Why?
|
Pregnancy Outcome | 2 | 2022 | 2795 | 0.100 |
Why?
|
Induced Pluripotent Stem Cells | 2 | 2014 | 1728 | 0.100 |
Why?
|
Ergolines | 1 | 2010 | 60 | 0.090 |
Why?
|
Molecular Sequence Annotation | 1 | 2013 | 527 | 0.090 |
Why?
|
Telomere | 1 | 2016 | 909 | 0.090 |
Why?
|
Retinal Diseases | 1 | 2016 | 683 | 0.090 |
Why?
|
Treatment Outcome | 5 | 2020 | 62966 | 0.090 |
Why?
|
Cell Proliferation | 2 | 2016 | 10472 | 0.090 |
Why?
|
Meiosis | 1 | 2012 | 338 | 0.090 |
Why?
|
Attitude to Health | 1 | 2019 | 2051 | 0.090 |
Why?
|
Environment | 1 | 2016 | 1115 | 0.090 |
Why?
|
Internationality | 1 | 2015 | 1002 | 0.090 |
Why?
|
Sequence Analysis, DNA | 2 | 2018 | 4801 | 0.080 |
Why?
|
Staphylococcal Infections | 1 | 2018 | 1398 | 0.080 |
Why?
|
Mice | 7 | 2023 | 81045 | 0.080 |
Why?
|
Risk Factors | 5 | 2019 | 72145 | 0.080 |
Why?
|
DNA Methylation | 2 | 2021 | 4282 | 0.080 |
Why?
|
Gene Regulatory Networks | 2 | 2016 | 1707 | 0.080 |
Why?
|
Models, Theoretical | 1 | 2020 | 3584 | 0.080 |
Why?
|
Young Adult | 4 | 2021 | 56350 | 0.080 |
Why?
|
Receptors, Dopamine D2 | 1 | 2010 | 475 | 0.080 |
Why?
|
Cooperative Behavior | 1 | 2015 | 1503 | 0.080 |
Why?
|
DNA Primers | 1 | 2012 | 2892 | 0.080 |
Why?
|
Dopamine Agonists | 1 | 2010 | 355 | 0.080 |
Why?
|
Ligands | 1 | 2014 | 3293 | 0.080 |
Why?
|
Calcinosis | 1 | 2016 | 1497 | 0.070 |
Why?
|
Cell Movement | 1 | 2019 | 5212 | 0.070 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2012 | 1213 | 0.070 |
Why?
|
Risk Assessment | 2 | 2019 | 23320 | 0.070 |
Why?
|
Prospective Studies | 5 | 2022 | 53187 | 0.070 |
Why?
|
Myoma | 1 | 2006 | 10 | 0.070 |
Why?
|
Polymerase Chain Reaction | 1 | 2016 | 6171 | 0.070 |
Why?
|
Comparative Genomic Hybridization | 2 | 2020 | 496 | 0.070 |
Why?
|
Gene Expression | 1 | 2019 | 7790 | 0.070 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2015 | 3920 | 0.070 |
Why?
|
MicroRNAs | 2 | 2019 | 3731 | 0.070 |
Why?
|
Mullerian Ducts | 1 | 2006 | 198 | 0.070 |
Why?
|
RNA-Binding Proteins | 2 | 2012 | 1899 | 0.070 |
Why?
|
Escherichia coli | 1 | 2018 | 4214 | 0.070 |
Why?
|
Oocyte Donation | 2 | 2019 | 49 | 0.070 |
Why?
|
Adult | 7 | 2021 | 213712 | 0.070 |
Why?
|
Recurrence | 1 | 2017 | 8333 | 0.070 |
Why?
|
Gene Expression Regulation | 4 | 2016 | 12071 | 0.060 |
Why?
|
Regenerative Medicine | 1 | 2009 | 306 | 0.060 |
Why?
|
Receptors, Cell Surface | 1 | 2014 | 2867 | 0.060 |
Why?
|
DNA, Mitochondrial | 2 | 2023 | 814 | 0.060 |
Why?
|
Phenotype | 3 | 2016 | 16331 | 0.060 |
Why?
|
Seizures | 1 | 2016 | 2851 | 0.060 |
Why?
|
Mutation | 3 | 2021 | 29717 | 0.060 |
Why?
|
Oxidants | 1 | 2004 | 164 | 0.060 |
Why?
|
Disease Models, Animal | 2 | 2019 | 18006 | 0.060 |
Why?
|
International Cooperation | 1 | 2010 | 1421 | 0.060 |
Why?
|
Up-Regulation | 1 | 2012 | 4211 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12242 | 0.050 |
Why?
|
Sensitivity and Specificity | 1 | 2018 | 14720 | 0.050 |
Why?
|
Genetic Markers | 2 | 2021 | 2633 | 0.050 |
Why?
|
Aging | 2 | 2024 | 8626 | 0.050 |
Why?
|
Case-Control Studies | 2 | 2016 | 21719 | 0.050 |
Why?
|
Synaptonemal Complex | 2 | 2012 | 25 | 0.050 |
Why?
|
Semen | 1 | 2004 | 316 | 0.050 |
Why?
|
Logistic Models | 1 | 2016 | 13403 | 0.050 |
Why?
|
Base Sequence | 1 | 2012 | 12797 | 0.050 |
Why?
|
Genomics | 1 | 2016 | 5692 | 0.050 |
Why?
|
Anti-Mullerian Hormone | 1 | 2022 | 399 | 0.040 |
Why?
|
Muscle, Smooth | 1 | 2024 | 933 | 0.040 |
Why?
|
Coculture Techniques | 2 | 2014 | 1341 | 0.040 |
Why?
|
Biomedical Research | 1 | 2015 | 3306 | 0.040 |
Why?
|
Biomass | 1 | 2019 | 125 | 0.040 |
Why?
|
Inflammation | 1 | 2019 | 10578 | 0.040 |
Why?
|
Body Mass Index | 1 | 2016 | 12695 | 0.040 |
Why?
|
Genitalia, Female | 1 | 2019 | 146 | 0.040 |
Why?
|
Muscle Contraction | 1 | 2024 | 1241 | 0.040 |
Why?
|
Sperm Injections, Intracytoplasmic | 1 | 2019 | 160 | 0.040 |
Why?
|
Virulence | 1 | 2022 | 1328 | 0.040 |
Why?
|
Semen Analysis | 1 | 2019 | 204 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2015 | 19862 | 0.040 |
Why?
|
Infant | 1 | 2019 | 35070 | 0.040 |
Why?
|
Endometrial Neoplasms | 1 | 2006 | 1351 | 0.040 |
Why?
|
Chromosomes | 1 | 2020 | 595 | 0.040 |
Why?
|
Prognosis | 1 | 2017 | 29010 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2010 | 11363 | 0.030 |
Why?
|
Antioxidants | 1 | 2004 | 1659 | 0.030 |
Why?
|
Texas | 1 | 2016 | 392 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 2016 | 8829 | 0.030 |
Why?
|
United States | 2 | 2019 | 69693 | 0.030 |
Why?
|
Child | 1 | 2023 | 77478 | 0.030 |
Why?
|
Oocyte Retrieval | 1 | 2016 | 161 | 0.030 |
Why?
|
Embryo Culture Techniques | 1 | 2014 | 80 | 0.030 |
Why?
|
Genital Neoplasms, Female | 1 | 2019 | 516 | 0.030 |
Why?
|
Obesity | 1 | 2016 | 12705 | 0.030 |
Why?
|
Fallopian Tubes | 1 | 2014 | 182 | 0.030 |
Why?
|
Receptors, Cytokine | 1 | 2014 | 261 | 0.030 |
Why?
|
Receptors, Growth Factor | 1 | 2014 | 334 | 0.030 |
Why?
|
Journal Impact Factor | 1 | 2015 | 156 | 0.030 |
Why?
|
Expert Testimony | 1 | 2016 | 356 | 0.030 |
Why?
|
Chromosome Aberrations | 1 | 2020 | 1811 | 0.030 |
Why?
|
Ovum | 1 | 2014 | 189 | 0.030 |
Why?
|
California | 1 | 2016 | 1400 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 2 | 2012 | 3770 | 0.030 |
Why?
|
Growth Substances | 1 | 2014 | 783 | 0.030 |
Why?
|
Incidence | 2 | 2021 | 20928 | 0.030 |
Why?
|
Haploidy | 1 | 2010 | 136 | 0.020 |
Why?
|
Hormones | 1 | 2014 | 884 | 0.020 |
Why?
|
HLA Antigens | 1 | 2016 | 1382 | 0.020 |
Why?
|
History, 20th Century | 1 | 2018 | 2739 | 0.020 |
Why?
|
Molecular Biology | 1 | 2014 | 595 | 0.020 |
Why?
|
Risk Reduction Behavior | 1 | 2016 | 1123 | 0.020 |
Why?
|
Antigens, Differentiation | 1 | 2012 | 926 | 0.020 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2010 | 772 | 0.020 |
Why?
|
Fibronectins | 1 | 2012 | 723 | 0.020 |
Why?
|
RNA, Untranslated | 1 | 2012 | 454 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2016 | 1402 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2012 | 1547 | 0.020 |
Why?
|
Middle Aged | 2 | 2021 | 213127 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2021 | 3639 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2010 | 544 | 0.020 |
Why?
|
Adolescent | 2 | 2012 | 85649 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2015 | 77098 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2022 | 12958 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2012 | 2088 | 0.020 |
Why?
|
Cell Survival | 1 | 2016 | 5872 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2012 | 3139 | 0.020 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2010 | 838 | 0.020 |
Why?
|
Zebrafish | 1 | 2016 | 2990 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2016 | 2896 | 0.020 |
Why?
|
Glycoproteins | 1 | 2012 | 2260 | 0.010 |
Why?
|
Life Style | 1 | 2016 | 3824 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2012 | 1989 | 0.010 |
Why?
|
Time Factors | 2 | 2016 | 40054 | 0.010 |
Why?
|
Mice, Nude | 1 | 2010 | 3689 | 0.010 |
Why?
|
Mitochondria | 1 | 2016 | 3520 | 0.010 |
Why?
|
Infertility, Male | 1 | 2004 | 407 | 0.010 |
Why?
|
Stress, Psychological | 1 | 2016 | 4229 | 0.010 |
Why?
|
Cytokines | 1 | 2014 | 7317 | 0.010 |
Why?
|
Calcium | 1 | 2012 | 5753 | 0.010 |
Why?
|
Age Factors | 1 | 2016 | 18355 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2010 | 2723 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2010 | 10943 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2004 | 2077 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2004 | 3081 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2010 | 15530 | 0.010 |
Why?
|
Concepts
(329)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(5)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_